General considerations by a clinical bacteriologist regarding antibiotic therapy in acne.
D000152:Acne Vulgaris / Q000188:drug therapy* / Q000382:microbiology; D000900:Anti-Bacterial Agents / Q000494:pharmacology / Q000627:therapeutic use*; D002981:Clindamycin / Q000627:therapeutic use; D004917:Erythromycin; D006801:Humans; D011425:Propionibacterium acnes / Q000187:drug effects; D011815:R Factors; D013420:Sulfamethoxazole / Q000627:therapeutic use; D013754:Tetracyclines / Q000627:therapeutic use; D014295:Trimethoprim / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D013754:Tetracyclines; D002981:Clindamycin; D004917:Erythromycin; D014295:Trimethoprim; D013420:Sulfamethoxazole